Previous studies on atherosclerosis have shown that there are a variety of lncRNAs, including MALAT1 [24], H19 [25], ATB [26], LEF1-AS1 [27], and ZEB1-AS1 [28], which are promising therapeutic targets. The gene discussed is MALAT1; the disease is atherosclerosis.